Thierry L.

Biography

Prof. Thierry Langer, Pharm MS, Ph.D., serves as the Chief Scientific Officer at Prestwick Chemical, Inc. Prof. Langer joined Prestwick Chemical, Inc., in April 2008. His previous employment had been Professor at Leopold-Franzens-University of Innsbruck, Austria, where he began his career after completing a post doctoral fellowship at the Université Louis Pasteur (Strasbourg, France) with Prof. C. G. Wermuth in 1992. In 2003, together with Prof. Stuppner and Dr. Wolber (University of Innsbruck, Austria), Prof. Langer founded the spin-off company Inte:Ligand GmbH, in which he also served as Chief Executive Officer prior to joining Prestwick Chemical, Inc. His research interests have been focused on computer-assisted medicinal chemistry, including pharmacophore-based methods as well as 3D-QSAR molecular modeling techniques. Prof. Langer served as CEO and Director of Prestwick Chemical, Inc. Since 1993, he established at Innsbruck University the Computer Aided Molecular Design Group, was appointed Associate Professor of Pharmaceutical Chemistry in 1997, and served as Head of the Institute of Pharmaceutical Chemistry and of the Pharmaceutical Chemistry Department in 1998 and 1999. Prof. Langer is a well known scientist in the field of computer aided molecular design: His scientific work has culminated in more than 150 original articles and invited reviews in peer reviewed journals, several book chapters, one edited book, and more than 200 presentations at scientific meetings. Prof. Langer holds an M.S. degree in Pharmacy (1988) and a Ph.D. in Medicinal Chemistry (1991) from the University of Vienna, Austria.

Research Interest

business